| Assessment of disease progression in dysferlinopathy: a 1-year cohort study U Moore, M Jacobs, MK James, AG Mayhew, R Fernandez-Torron, J Feng, ... Neurology 92 (5), e461-e474, 2019 | 28 | 2019 |
| Assessing dysferlinopathy patients over three years with a new motor scale MB Jacobs, MK James, LP Lowes, LN Alfano, M Eagle, R Muni Lofra, ... Annals of neurology 89 (5), 967-978, 2021 | 21 | 2021 |
| Assessing the relationship of patient reported outcome measures with functional status in dysferlinopathy: a rasch analysis approach AG Mayhew, MK James, U Moore, H Sutherland, M Jacobs, J Feng, ... Frontiers in neurology 13, 828525, 2022 | 7 | 2022 |
| Does the performance of upper limb capture functional variations in dysferlinopathy? M James, A Mayhew, D Moat, M Eagle, E Maron, R Gee, K Rose, B Drogo, ... Neuromuscular Disorders 27, S145-S146, 2017 | 2 | 2017 |
| P. 162 Clinical outcome study of dysferlinopathy: Performance of upper limb entry item to predict forced vital capacity in dysferlinopathy (LGMDR2) M James, HG Dressman, H Hilsden, L Rufibach, A Human, T Duong, ... Neuromuscular Disorders 32, S114, 2022 | 1 | 2022 |
| Table_1_Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach. docx AG Mayhew, MK James, U Moore, H Sutherland, M Jacobs, J Feng, ... Figshare, 2022 | | 2022 |
